Cardiology Cases Wrap Up Flashcards
INR goal for pt w.o artificial valve (non-mechanical)
2.0-3.0
INR goal for pt w. artificial valve (mechanical)
2.5-3.5
when can you use the term “coumadin failure”
only if pt was on therapeutic dose when fail occurred
otherwise, it’s subtherapeutic fail
t/f: a single coumadin dose can affect INR
t!
need to know what dose pt was on when INR was obtained
best AC for severe renal dz or ESRD
warfarin
AC for pt w. mechanical valve
warfarin
2 cons of warfarin
narrow therapeutic index -> must check INR
many food/ddi
3 benefits of DOACs over warfarin
fewer interactions
less ICH/fatal bleeding
bridging not needed (rapid onset/offset)
4 cons of DOACs
expensive
some lack or have expensive reversal agents
higher rate of GIB
not approved in ESRD
warfarin has a higher rate of __ bleeds
DOACs have a higher rate of __ bleeds
warfarin: ICH/fatal
DOACs: GIB/non fatal
what are the 4 doac’s
dabigatran (pradaxa)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
dabigatran is a __ inhibitor, whereas the other 3 doac’s are __ inhibitors
dabigatran: direct thrombin
others: Xa
jaynstein’s go to doac
apixaban (eliquis)
CHADSVASC
afib rate control: strict vs lenient vs exertional
strict: < 80
lenient: < 110
exertional: < 115
options for chronic rate control in afib (2)
bb
ccb (non dihydropiridines -> diltiazem, verapamil)
2 conditions that digoxin is used for
HFrEF
afib
only for pt w. inadequate rate control w. bb and/or ccb
which ac’s have reversal agents
warfarin
dabigatran (pradaxa)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
reversal agent for dabigatran
praxbind
andexxa is the reversal agent for (3)
rivaroxaban (xarelto)
apixaban (eliquis)
edoxaban (savaysa)
5 s.e of hctz
hypo’s:
hyponatremia
hypokalemia
hypomagnesemia
hypochloremic alkalosis
plus hyperglycemia and hyperuricemia
caution w. hctz in what 2 conditions
gout
DM
which mucinex is contraindicated w. htn
mucinex d - the d is pseudoephedrine (can cause htn)
regular mucinex is ok
2 common s.e of norvasc (amlodipine)
peripheral edema
fatigue
bp goal for htn + dm
< 130/80
ideal classes of meds for htn + dm (3)
diuretics
acei/arb
ccb
what ccb are best for htn + dm
dihydropiridines (amlodipine/novasc)
life threatening s.e of amlodipine
angina/MI
hypotn
pulmonary edema
use amlodipine w. extreme caution in what 2 conditions
AS - can cause MI
CHF - can decrease afterload
ccb work best for htn for what patient population
AA
life threatening s.e of ACEI (6)
angioedema
cholestatic jaundice -> fulminant hepatic necrosis
hyperkalemia
ARF
hypotn
severe hypersensitivity
angioedema manifesting as abdominal pain may occur more often in what pt pop
AA
common s.e of ACEI (4)
hyperkalemia
elevated Cr
dizzy
cough
life threatening s.e of bb (4)
AV block
bradycardia
CNS dpn
hypotn
common s.e of bb (4)
hypotn
bradycardia
dizzy
worsen raynaud or peripheral vascular dz
life threatening s.e of hctz (2)
severe lyte disturbance
angle-closure glaucoma
common s.e of ARBs (3)
cough
hyperkalemia
elevated Cr
life threatening s.e of ARBs (4)
angioedema
hyperkalemia
hypotn
renal fxn decline
t/f: if a pt has a cough w. lisinopril, you should try losartan
t!
t/f: if a pt has angioedema w. lisinopril you should try losartan
hell no! why would you think you can do this you idiot?!
jk… i thought you could too
what class of drug is clonidine
alpha blocker
common s.e of clonidine (6)
xerostomia
drowsy
ha
fatigue
dizzy
transient skin rash
3 life threatening s.e of clonidine
bradycardia
cns dpn
hypotn
which ccb is extended release
diltiazem
4 common s.e of diltiazem
peripheral edema
ha
bradycardia
dizzy
4 life threatening s.e of diltiazem
av block
bradycardia
sjs
hypotn
moa of hydralazine
vasodilator
indication for hydralazine
acute htn episodes (usually inpt setting)
not really used for long term control
t/f: you should treat asymptomatic htn acutely in the op setting
f!
don’t do it
just address stricter control of long term meds
common s.e of hydralazine (6)
earache
tachy
palpitations
angina
n/v
diarrhea
3 life threatening s.e of hydralazine
lupus-like syndrome
blood dyscrasia
MI
2 contraindications for hydralazine
CAD
peripheral neuritis
what was our plan for pt w. htn and gout (4)
d/c hctz and mucinex
add lisinopril
continue norvasc
increase metformin
when do you use the 10 year ascvd risk to decide if your pt needs statin as primary prevention
if ldl is > 100
basic ascvd risk guidelines for statin as primary prevention (2)
7.5 or higher - 10% risk = statin
if LDL 190 or higher
statins reduce cv risk __%
20-30
how should you dose statin as secondary prevention
highest dose pt can tolerate
lifelong high intensity statin regardless of ldl
2 high dose statins
atorvastatin (lipitor) 40-80
rosuvastatin (crestor) 20-40
t/f: doubling of statin dose produces double decrease in ldl
f! - only additional 6% decrease
what should you consider if you are thinking about doubling your pt’s statin dose
adding a second med instead
when do LFTs need to be monitored for pt on statin (3)
before initiation
annually
any dose increase
2 contraindications for statins
liver disease (don’t forget AUD)
pregnancy
common s.e of statins (5)
photosensitivity
arthralgias
GI upset
nasopharyngitis
elevated LFTs
4 life threatening s.e of statins
rhabdo
arf
hepatotoxic
hemorrhagic stroke
3 rf for statin related myopathy
small body frame
multisystem diseases
multiple meds
what do you think when you see: new onset renal failure, dark urine, confusion
rhabdo
t/f: cpk monitoring is recommended for pt on statin
f!
only in symptomatic pt
2 types of stents
des: drug eluting stent
bms: bare metal stent
antiplatelet recommendation for both kinds of stent
at least 6-12 mo of dual antiplatelet therapy (dapt): clopidigrel PLUS ASA
longer (18-24 mo) if pt has no major or moderate bleeding events
ASA dose for DAPT
81 mg
what do you use to predict combined ischemic and bleeding risk for pt’s being considered to continue dapt therapy beyond one year
dapt score
2 common s.e of plavix
bleeding
pruritis
6 life threatening s.e of plavix
severe bleeding
TTP
agranulocytosis
SJS/TEN
aplastic anemia
pancytopenia
when would you use 325 mg ASA
only for AMI and ischemic stroke
use 81 mg for daily dose
interaction and contraindication for asa
interaction: nsaids
contraindication: GIB
asa is only recommended for __ prevention
secondary
only anti anginal med proven to improve survival and prevent re-infarction in pt who have had MI
bb
first line therapy for acute angina symptoms
nitrates
when are ccb used for angina
in combo w. bb when monotherapy is inadequate
all bb are equally effective for angina, but which ones are recommended dt less systemic s.e profile
cardioselective: metoprolol, atenolol
bb improve survival in what 2 conditions
prior MI
HFrEF
bb decrease efficacy of (3)
thyroid meds
insulin
oral hypoglycemics
contraindications for bb (6)
uncompensated HF
cardiogenic shock
2nd or 3rd degree heart block
bradycardia
COPD/asthma
hypotn
4 life threatening s.e of bb
hypotn
bradycardia
syncope
av blocks
4 common s.e of bb
fatigue
rash
dizzy
impotence
contraindications for nitrates (7)
obstructive hypertrophic cardiomyopathy
hypovolemia
inferior MI w. right ventricular involvement
elevated ICP
cardiac tamponade
sbp < 90
ED meds w.in past 24 hr
pt ed for nitrate patch
must remove for 12-24 hr (keep on from 8a-8p)
which nitrate is used for chronic/preventive management of angina
isosorbide mononitrate (imdur)
moa for nitrates
vasodilate -> decrease preload -> reduce myocardial O2 demand
4 common s.e of nitrates
HA
flushing
hypotn
syncope
5 life threatening s.e of nitrates
hypotn
paradoxical bradycardia
syncope
increased ICP
ddi w. pde5 inhibitors
antianginal drug that is not a nitrate
ranolazine (ranexa)
moa for ranolazine
partial fatty aid oxidation inhibitor -> alters myocardial energy metabolism -> decreases cardiac work load
how is ranolazine used for angina
prevention
not acute
2 s.e of ranolazine
hypotn
bradycardia
3 ddi’s to be aware of w. commonly prescribed CV drugs
ASA + plavix -> increased bleed risk
nitro + bb -> additive hypotn
nitro + viagra -> additive hypotn
what are the ABCDE’s of post MI drugs
A: antiplatelet -> asa + plavix
B: bp control -> bb
C: cholesterol -> statin
D: diet
E: exercise
moa for loop diuretics
inhibit Na and Cl resorption -> urinary excretion of Na, Cl, K
reduce peripheral vascular resistance and increase peripheral venous capacitance -> decrease LV filling pressure
2 mc loops diuretics
furosemide
torsemide
t/f: loop diuretic effect is dose dependent
t!
common s.e of loop diuretics (3)
hypokalemia
metabolic alkalosis
increased Cr
life threatening s.e of loop diuretics (7)
hypokalemia
hypotn
metabolic alkalosis
ARF
hyponatremia
hypersensitivity
ototoxicity -> deafness
tx for inpt in acute fluid overload
iv lasix
IV lasix has __ the bioavailability of oral
twice
if on 40 mg po lasix, start 20 IV
indication for IV lasix
breathing difficulty
not just peripheral edema
when is torsemide used
if lasix fails
but if pt was on torsemide at home, choose torsemide inpt
4 meds that can contribute to HF
NSAIDs
antiarrhythmics
CCB
hctz
5 meds that improve mortality in HFrEF
spironolactone (NYHA III and/or IV)
hydralazine + nitrates
acei/arb
bb
4 meds that do NOT improve mortality in HFrEF
ccb
digoxin
diuretics
nesritide (don’t worry about this mystery drug)
benefits of digoxin (2)
improves functional capacity
decreases hospitalization
moa for digoxin
positive inotrope -> increases contractility
indication for digoxin
3rd/4th line for symptom control (fatigue, dyspnea, exercise intolerance) in pt’s already on appropriate therapy
3 drugs that increase serum levels of digoxin
amiodarone
quinidine
verapamil
never give dig to what type of HFrEF pt
acutely decompensated
rf for dig toxicity (6)
low body wt
advanced age
renal impairment
hypokalemia
hypercalcemia
hypomagnesemia
symptoms of dig toxicity (8)
GI sx
cardiac sx
AMS
anorexia
NVD
vision changes
lyte abnormalities -> hyperkalemia
arrhythmias
how is dig cleared
renally
what class of drug is spironolactone
aldosterone receptor antagonist
common s.e of spironolactone (5)
hyperkalemia
dizzy
n/v
gynecomastia
menstrual irregularities
life threatening s.e of spironolactone (4)
hyperkalemia
ARF
hypotn
hepatotoxicity
analgesic of choice in CHF pt
APAP
3 ddi’s to be aware of in CHF pt
lisinopril + KCl + spironolactone -> hyperkalemia
lisinopril + bb + lasix -> hypotn
ASA + plavix -> bleeding d.o
t/f: furosemide is superior to torsemide and bumetanide
f!
torsemide might actually be more potent and effective
how does renal failure impact diuretic dosing
increased dosing as gfr decreases
only contraindication for lasix
anuria
unless pt is on dialysis
t/f: bb and ccb are commonly used together in HFrEF
no they shouldn’t be
what’s the matter w. androgel in HFrEF
risk of major cv events
risk of increased HTN
what bp med do you think of when you see abdominal cramps
lasix
life threatening s.e of levothyroxine
CHF
arrhythmina
sz
SJS/TEN
common s.e of levothyroxine
ha
anxiety
diaphoresis
palpitations
diarrhea
anxiety
tremor
wt loss
heat intolerance
hair loss
can pt increase dose of lasix for acute edema in op setting
yep!
give them an extra dose